Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

You have always had your finger on the royalty pulse and your predictions have been dead on. You don't see a problem there and that's that as far as I'm concerned. That's not to say that we are clear sailing. We are still integrating the acquisition and there might be unexpected cost burdens, for example. Still, I just think someone is liquidating their position for external reasons and traders are taking advantage. JMHO.